BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7048442)

  • 1. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
    Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
    Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic ambulatory peritoneal dialysis.
    Harrington JT
    N Engl J Med; 1982 Mar; 306(11):670-1. PubMed ID: 7035948
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
    Triolo G; Carta Q; Salomone M; Dani F; Passarino G; Boggio Bertinet D; Segoloni GP; Vercellone A
    Life Support Syst; 1983; 1 Suppl 1():454-6. PubMed ID: 6400733
    [No Abstract]   [Full Text] [Related]  

  • 6. Administration of insulin by continuous ambulatory peritoneal dialysis.
    Chan E; Montgomery PA
    Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
    Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraperitoneal versus subcutaneous insulin in patients on nighttime IPD.
    Bargman JM
    Adv Perit Dial; 1994; 10():116-9. PubMed ID: 7999807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis considerations for diabetic patients.
    Khanna R
    Kidney Int Suppl; 1993 Feb; 40():S58-64. PubMed ID: 8445840
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peritoneal dialysis for diabetic nephropathy: a case of intraperitoneal insulin administration].
    Abe T; Kusumi H; Kanazawa M
    Hinyokika Kiyo; 1972 Mar; 18(3):133-6. PubMed ID: 5065298
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-bag CAPD with intraperitoneal insulin. Satisfactory management of diabetes and its major complications in uremic patients].
    Bazzato G; Lucatello S; Coli U; Landini S; Fracasso A; Morachiello P; Fabbro A
    Minerva Nefrol; 1981; 28(3):345-52. PubMed ID: 7036017
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of NovoPen in diabetic patients on CAPD.
    Van Crombrugge P
    Diabetes Care; 1988 Apr; 11(4):373-4. PubMed ID: 3042314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
    Nevalainen P; Lahtela J; Mustonen J; Pasternack A
    Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin absorption from the peritoneal cavity.
    Zingg W; Leibel BS
    Life Support Syst; 1985; 3(4):335-42. PubMed ID: 3906287
    [No Abstract]   [Full Text] [Related]  

  • 15. Peritoneal dialysis in diabetic patients.
    Bertoli M; Bonfante L; Gambaro G; Cara M; Virgilio B; D'Angelo A
    Contrib Nephrol; 2001; (131):51-60. PubMed ID: 11125563
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased subcutaneous insulin requirements in diabetic patients recently commenced on peritoneal dialysis.
    Szeto CC; Chow KM; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Jun; 22(6):1697-702. PubMed ID: 17259649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
    Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
    Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraperitoneal insulin in diabetic CAPD patients.
    Mactier RA; Khanna R
    Int J Artif Organs; 1988 Jan; 11(1):9-12. PubMed ID: 3283057
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the uptake of human and porcine insulins given intraperitoneally to patients with diabetes mellitus on continuous ambulatory peritoneal dialysis.
    Webb DB; Banks RA; Browning MJ; Luzio SD; Winning RC
    Diabetes Res; 1986 Feb; 3(2):103-6. PubMed ID: 3516521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal insulin: new alternative for diabetic CAPD patients.
    Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N
    AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.